{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T18:00:00Z","timestamp":1780768800794,"version":"3.54.1"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Uptake of the measles\u2013mumps\u2013rubella vaccine in Wales is high. However, sporadic measles cases still occur and there are large mumps outbreaks every few years. In this study, the long-term vaccine effectiveness (VE) of vaccines containing measles and mumps is assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort of 822\u2009116 individuals aged 1\u201330\u2009years were followed up between 1 January 2007 and 31 December 2020. Welsh Demographic Service data were linked to vaccination status from the national vaccination register and primary care records. Outcomes were identified by linking to laboratory confirmations (measles and mumps) and notifications (mumps) data. Complications were sourced from hospital admissions and primary care data. Extended Cox regression was used to calculate hazard ratios.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The adjusted VE (aVE) against confirmed measles after two doses remained high after 15\u2009years 99.7% [95% confidence interval (CI) 99.2\u201399.9]. The aVE for confirmed mumps was lower, with decline over time: 93.6% (95% CI 90.2\u201395.8) in the first 5 years after vaccination with dose two and 49.9% (95% CI 34.4\u201361.8) after \u226515\u2009years. A third dose of mumps vaccine temporarily increases protection (87.6%, 95% CI 71.7\u201394.6). The aVE estimates for mumps were lower when based on clinical suspicion. The VE was high against complications for both infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The high, sustained VE for measles strengthens evidence that elimination remains possible and the high VE against mumps complications is encouraging. Evidence for the waning of mumps immunity may be important when deciding to implement a third dose in outbreak settings. With the increased use of data linkage, studies should be conducted to corroborate these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ije\/dyag083","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:24:33Z","timestamp":1778585073000},"source":"Crossref","is-referenced-by-count":0,"title":["Estimates of vaccine effectiveness against measles and mumps: 14 years follow-up of a large cohort in Wales, UK"],"prefix":"10.1093","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1397-5934","authenticated-orcid":false,"given":"Malorie","family":"Perry","sequence":"first","affiliation":[{"name":"Population Data Science, Health Data Research UK, Swansea University Medical School , Swansea, SA2 8PP, Wales,","place":["United Kingdom"]},{"name":"Vaccine Preventable Disease Programme and Communicable Disease Surveillance Centre, Public Health Wales , Cardiff, CF10 4BZ, Wales,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B","family":"Gravenor","sequence":"additional","affiliation":[{"name":"Population Data Science, Health Data Research UK, Swansea University Medical School , Swansea, SA2 8PP, Wales,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Cottrell","sequence":"additional","affiliation":[{"name":"Vaccine Preventable Disease Programme and Communicable Disease Surveillance Centre, Public Health Wales , Cardiff, CF10 4BZ, Wales,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Moore","sequence":"additional","affiliation":[{"name":"Wales Specialist Virology Centre, University Hospital of Wales , Cardiff, CF14 4XW, Wales,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy J","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Population Data Science, Health Data Research UK, Swansea University Medical School , Swansea, SA2 8PP, Wales,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"2026060613224031200_dyag083-B1","author":"UK Health Security Agency","year":"2019"},{"key":"2026060613224031200_dyag083-B2","author":"Oxford University","year":"2024"},{"key":"2026060613224031200_dyag083-B3","author":"Public Health Wales","year":"2025"},{"key":"2026060613224031200_dyag083-B4","author":"World Health Organization","year":"2020"},{"key":"2026060613224031200_dyag083-B5","author":"Public Health Wales","year":"2025"},{"key":"2026060613224031200_dyag083-B6","author":"Public Health Wales","year":"2025"},{"key":"2026060613224031200_dyag083-B7","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1093\/infdis\/jir102","article-title":"Field effectiveness of live attenuated measles-containing vaccines: a review of published literature","volume":"204 Suppl 1","author":"Uzicanin","year":"2011","journal-title":"J Infect Dis"},{"key":"2026060613224031200_dyag083-B8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.21101\/cejph.a4754","article-title":"Assessment of vaccine effectiveness during measles outbreak in the Federation of Bosnia and Herzegovina, 2014-2015","volume":"26","author":"Musa","year":"2018","journal-title":"Cent Eur J Public Health"},{"key":"2026060613224031200_dyag083-B9","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/INF.0000000000003111","article-title":"Effectiveness of \"Priorix\" against measles and mumps diseases in children born after 2004 in the United Kingdom: a retrospective case-control study using the clinical practice research datalink GOLD database","volume":"40","author":"Povey","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"2026060613224031200_dyag083-B10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5365\/WPSAR.2015.6.2.007","article-title":"An assessment of measles vaccine effectiveness, Australia, 2006-2012","volume":"6","author":"Pillsbury","year":"2015","journal-title":"Western Pac Surveill Response J"},{"key":"2026060613224031200_dyag083-B11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12887-019-1710-5","article-title":"Childhood MMR vaccination and the incidence rate of measles infection: a ten year longitudinal cohort study of American children born in the 1990s","volume":"19","author":"Geier","year":"2019","journal-title":"BMC Pediatr"},{"key":"2026060613224031200_dyag083-B12","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1080\/21645515.2017.1330733","article-title":"The effectiveness of measles-mumps-rubella (MMR) vaccination in the prevention of pediatric hospitalizations for targeted and untargeted infections: a retrospective cohort study","volume":"13","author":"La Torre","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"2026060613224031200_dyag083-B13","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.3346\/jkms.2017.32.11.1876","article-title":"An outbreak of measles in a University in Korea, 2014","volume":"32","author":"Choe","year":"2017","journal-title":"J Korean Med Sci"},{"key":"2026060613224031200_dyag083-B14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1086\/520028","article-title":"Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines","volume":"45","author":"Peltola","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2026060613224031200_dyag083-B15","doi-asserted-by":"publisher","first-page":"eaao5945","DOI":"10.1126\/scitranslmed.aao5945","article-title":"Vaccine waning and mumps re-emergence in the United States","volume":"10","author":"Lewnard","year":"2018","journal-title":"Sci Transl Med"},{"key":"2026060613224031200_dyag083-B16","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1016\/j.vaccine.2010.02.107","article-title":"Mumps vaccine effectiveness in highly immunized populations","volume":"28","author":"Dom\u00ednguez","year":"2010","journal-title":"Vaccine"},{"key":"2026060613224031200_dyag083-B17","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1016\/j.vaccine.2004.10.020","article-title":"The effectiveness of the mumps component of the MMR vaccine: a case control study","volume":"23","author":"Harling","year":"2005","journal-title":"Vaccine"},{"key":"2026060613224031200_dyag083-B18","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMoa1703309","article-title":"Effectiveness of a third dose of MMR vaccine for mumps outbreak control","volume":"377","author":"Cardemil","year":"2017","journal-title":"N Engl J Med"},{"key":"2026060613224031200_dyag083-B19","doi-asserted-by":"publisher","first-page":"e862","DOI":"10.1542\/peds.2006-3451","article-title":"Effectiveness of previous mumps vaccination during a summer camp outbreak","volume":"120","author":"Schaffzin","year":"2007","journal-title":"Pediatrics"},{"key":"2026060613224031200_dyag083-B20","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.23889\/ijpds.v4i2.1134","article-title":"A profile of the SAIL databank on the UK secure research platform","volume":"4","author":"Jones","year":"2019","journal-title":"Int J Popul Data Sci"},{"key":"2026060613224031200_dyag083-B21","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/vaccines11030680","article-title":"Determinants of equity in coverage of measles-containing vaccines in Wales, UK, during the Elimination Era","volume":"11","author":"Perry","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"2026060613224031200_dyag083-B22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.21037\/atm.2018.02.12","article-title":"Time-varying covariates and coefficients in Cox regression models","volume":"6","author":"Zhang","year":"2018","journal-title":"Ann Transl Med"},{"key":"2026060613224031200_dyag083-B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","article-title":"mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Soft"},{"key":"2026060613224031200_dyag083-B24","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/sim.3618","article-title":"Imputing missing covariate values for the Cox model","volume":"28","author":"White","year":"2009","journal-title":"Stat Med"},{"key":"2026060613224031200_dyag083-B25","author":"Haile","year":"2019"},{"key":"2026060613224031200_dyag083-B26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/oxfordjournals.epirev.a036023","article-title":"Assessing vaccine efficacy in the field. Further observations","volume":"10","author":"Orenstein","year":"1988","journal-title":"Epidemiol Rev"},{"key":"2026060613224031200_dyag083-B27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ije\/dyac207","article-title":"Estimation of vaccine effectiveness using the screening method","volume":"52","author":"Farrington","year":"2023","journal-title":"Int J Epidemiol"},{"key":"2026060613224031200_dyag083-B28","doi-asserted-by":"publisher","first-page":"ofw064","DOI":"10.1093\/ofid\/ofw064","article-title":"Measles outbreak associated with low vaccine effectiveness among adults in Pohnpei State, Federated States of Micronesia, 2014","volume":"3","author":"Hales","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2026060613224031200_dyag083-B29","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/00006454-199907000-00010","article-title":"Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella vaccine","volume":"18","author":"Vitek","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"2026060613224031200_dyag083-B30","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1097\/INF.0b013e318060aca1","article-title":"Large measles outbreak at a German public school, 2006","volume":"26","author":"Wichmann","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"2026060613224031200_dyag083-B31","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/s0264-410x(02)00482-6","article-title":"Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population of Poland","volume":"21","author":"Janaszek","year":"2003","journal-title":"Vaccine"},{"key":"2026060613224031200_dyag083-B32","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1017\/s0950268800051797","article-title":"Successful control of a school based measles outbreak by immunization","volume":"113","author":"Lyons","year":"1994","journal-title":"Epidemiol Infect"},{"key":"2026060613224031200_dyag083-B33","author":"Department of Health & Social Care","year":"2022"},{"key":"2026060613224031200_dyag083-B34","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/cid\/cis439","article-title":"Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age","volume":"55","author":"De Serres","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2026060613224031200_dyag083-B35","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1016\/j.vaccine.2023.08.018","article-title":"Two-dose measles vaccine effectiveness remains high over time: a French observational study, 2017-2019","volume":"41","author":"Franconeri","year":"2023","journal-title":"Vaccine"},{"key":"2026060613224031200_dyag083-B36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1017\/s0950268800057824","article-title":"Measles vaccine: a 27-year follow-up","volume":"112","author":"Ramsay","year":"1994","journal-title":"Epidemiol Infect"},{"key":"2026060613224031200_dyag083-B37","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/infdis\/jiw586","article-title":"Effectiveness of early measles, mumps, and rubella vaccination among 6-14-month-old infants during an epidemic in the Netherlands: an observational cohort study","volume":"215","author":"Woudenberg","year":"2017","journal-title":"J Infect Dis"},{"key":"2026060613224031200_dyag083-B38","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/infdis\/jiac039","article-title":"In elimination settings, measles antibodies wane after vaccination but not after infection: a systematic review and meta-analysis","volume":"226","author":"Bolotin","year":"2022","journal-title":"J Infect Dis"},{"key":"2026060613224031200_dyag083-B39","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S1473-3099(20)30442-4","article-title":"Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis","volume":"21","author":"Schenk","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2026060613224031200_dyag083-B40","doi-asserted-by":"publisher","first-page":"e766","DOI":"10.1016\/S2468-2667(24)00181-6","article-title":"Long-term waning of vaccine-induced immunity to measles in England: a mathematical modelling study","volume":"9","author":"Robert","year":"2024","journal-title":"Lancet Public Health"},{"key":"2026060613224031200_dyag083-B41","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1016\/j.vaccine.2012.02.035","article-title":"Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008","volume":"30","author":"Snijders","year":"2012","journal-title":"Vaccine"},{"key":"2026060613224031200_dyag083-B42","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.eimc.2014.09.011","article-title":"An outbreak of mumps in a high school: Estimation of vaccine effectiveness. Zaragoza 2011","volume":"33","author":"Comp\u00e9s-Dea","year":"2015","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2026060613224031200_dyag083-B43","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/infdis\/158.6.1253","article-title":"A large outbreak of mumps in the postvaccine era","volume":"158","author":"Wharton","year":"1988","journal-title":"J Infect Dis"},{"key":"2026060613224031200_dyag083-B44","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.vaccine.2009.02.001","article-title":"Effectiveness of Jeryl Lynn-containing vaccine in Spanish children","volume":"27","author":"Castilla","year":"2009","journal-title":"Vaccine"},{"key":"2026060613224031200_dyag083-B45","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.vaccine.2013.11.021","article-title":"Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City","volume":"32","author":"Livingston","year":"2014","journal-title":"Vaccine"},{"key":"2026060613224031200_dyag083-B46","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1016\/j.vaccine.2012.04.083","article-title":"Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010","volume":"30","author":"Greenland","year":"2012","journal-title":"Vaccine"},{"key":"2026060613224031200_dyag083-B47","doi-asserted-by":"publisher","first-page":"e00542-16","DOI":"10.1128\/CVI.00542-16","article-title":"Challenges in interpretation of diagnostic test results in a mumps outbreak in a highly vaccinated population","volume":"24","author":"Trotz-Williams","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"2026060613224031200_dyag083-B48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3201\/eid1301.060649","article-title":"Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England","volume":"13","author":"Cohen","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"2026060613224031200_dyag083-B49","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/oxfordjournals.aje.a114037","article-title":"Clinical mumps vaccine efficacy","volume":"121","author":"Kim-Farley","year":"1985","journal-title":"Am J Epidemiol"},{"key":"2026060613224031200_dyag083-B50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12889-016-2958-4","article-title":"Protective effect of vaccination against mumps complications, Czech Republic, 2007-2012","volume":"16","author":"Orl\u00edkov\u00e1","year":"2016","journal-title":"BMC Public Health"},{"key":"2026060613224031200_dyag083-B51","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3201\/eid2004.131681","article-title":"Epidemic of mumps among vaccinated persons, The Netherlands, 2009-2012","volume":"20","author":"Sane","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2026060613224031200_dyag083-B52","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1080\/21645515.2015.1021522","article-title":"Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases","volume":"11","author":"Stein Zamir","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"2026060613224031200_dyag083-B53","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3201\/eid1801.111178","article-title":"Mumps vaccine effectiveness against orchitis","volume":"18","author":"Hahn\u00e9","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"2026060613224031200_dyag083-B54","author":"SAIL Databank","year":"2023"},{"key":"2026060613224031200_dyag083-B55","doi-asserted-by":"publisher","first-page":"S549","DOI":"10.1093\/infdis\/jir106","article-title":"Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals","volume":"204 Suppl 1","author":"Hickman","year":"2011","journal-title":"J Infect Dis"},{"key":"2026060613224031200_dyag083-B56","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.3390\/v13101982","article-title":"Measles in vaccinated people: epidemiology and challenges in surveillance and diagnosis in the post-elimination phase. Spain, 2014\u20132020","volume":"13","author":"L\u00f3pez-Perea","year":"2021","journal-title":"Viruses"},{"key":"2026060613224031200_dyag083-B57","doi-asserted-by":"publisher","first-page":"9551","DOI":"10.1016\/j.vaccine.2011.09.100","article-title":"Transmission of mumps virus from mumps-vaccinated individuals to close contacts","volume":"29","author":"Fanoy","year":"2011","journal-title":"Vaccine"},{"key":"2026060613224031200_dyag083-B58","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/S1473-3099(19)30395-0","article-title":"Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis","volume":"19","author":"Nic Lochlainn","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2026060613224031200_dyag083-B59","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.vaccine.2018.01.002","article-title":"Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review","volume":"36","author":"Guerra","year":"2018","journal-title":"Vaccine"}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ije\/article-pdf\/55\/3\/dyag083\/68484225\/dyag083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ije\/article-pdf\/55\/3\/dyag083\/68484225\/dyag083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T17:22:47Z","timestamp":1780766567000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ije\/article\/doi\/10.1093\/ije\/dyag083\/8703345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4,17]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/dyag083","relation":{},"ISSN":["0300-5771","1464-3685"],"issn-type":[{"value":"0300-5771","type":"print"},{"value":"1464-3685","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,4,17]]},"article-number":"dyag083"}}